News
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
2 Feb 24
Biotech, Earnings, Large Cap, News, Guidance, Health Care, Movers, General
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
29 Jan 24
Analyst Color, Biotech, Equities, Large Cap, News, Upgrades, Health Care, Analyst Ratings, Trading Ideas, General